Sign inGet started

Doyle Mittie

Insider CIK 1918845 · AVTX Chief Medical Officer · DICE Director · CGEM Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-08-282026-09-01679— $0113,734SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-08-282026-09-01679$20.00 $13.6K51,776SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-08-282026-09-01679$8.04 $5.5K52,455SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-08-282026-09-01679— $0113,734SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-08-282026-09-01679$20.00 $13.6K51,776SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-08-282026-09-01679$8.04 $5.5K52,455SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-08-172026-08-191,000— $0123,750SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-08-172026-08-191,000$12.65 $12.7K52,776SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-08-172026-08-191,000$20.00 $20.0K51,776SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-08-172026-08-191,000— $0123,750SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-08-172026-08-191,000$20.00 $20.0K51,776SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-08-172026-08-191,000$12.65 $12.7K52,776SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-08-102026-08-12679— $0114,413SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-08-102026-08-12679$20.00 $13.6K51,776SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-08-102026-08-12679$8.04 $5.5K52,455SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-08-102026-08-12679— $0114,413SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-08-102026-08-12679$20.00 $13.6K51,776SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-08-102026-08-12679$8.04 $5.5K52,455SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-07-272026-07-291,000— $0124,750SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-07-272026-07-291,000$12.65 $12.7K52,776SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-07-272026-07-291,000$20.00 $20.0K51,776SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-07-272026-07-291,000— $0124,750SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-07-272026-07-291,000$20.00 $20.0K51,776SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-07-272026-07-291,000$12.65 $12.7K52,776SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-06-302026-07-022,875— $0125,750SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-06-302026-07-021,779— $0115,092SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-06-302026-07-024,654$20.00 $93.1K51,776SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-06-302026-07-021,779$8.04 $14.3K56,430SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-06-302026-07-022,875$12.65 $36.4K54,651SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-06-232026-06-251,450— $0116,871SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-06-232026-06-251,450$8.04 $11.7K53,226SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-06-232026-06-251,450$18.00 $26.1K51,776SEC↗
CGEM Cullinan Therapeutics, Inc A Award deriv2026-06-162026-06-1821,781— $021,781SEC↗
AVTX Avalo Therapeutics, Inc. F Tax w/h2026-06-102026-06-121,084$13.10 $14.2K51,776SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-05-282026-06-01679— $0118,321SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-05-282026-06-01679$16.00 $10.9K47,122SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-05-282026-06-01679$8.04 $5.5K47,801SEC↗
AVTX Avalo Therapeutics, Inc. A Award2026-05-212026-05-2643,500— $047,122SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-05-152026-05-193,000— $0128,625SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-05-152026-05-193,000$12.65 $38.0K6,622SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-05-152026-05-193,000$18.76 $56.3K3,622SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-05-062026-05-0777,905— $0131,625SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-05-062026-05-0728,650— $0119,000SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-05-062026-05-0728,650$8.04 $230.3K110,177SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-05-062026-05-0777,905$12.65 $985.5K81,527SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-05-062026-05-0710,058$22.88 $230.1K3,622SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-05-062026-05-0727,538$18.03 $496.5K82,639SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-05-062026-05-075,000$19.65 $98.3K77,639SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-05-062026-05-0744,944$21.20 $952.8K32,695SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-05-062026-05-0719,015$22.41 $426.1K13,680SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-05-052026-05-071,000— $0209,530SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-05-052026-05-07679— $0147,650SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-05-052026-05-07679$8.04 $5.5K5,301SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-05-052026-05-071,000$12.65 $12.7K4,622SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-05-052026-05-071,679$16.00 $26.9K3,622SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-04-062026-04-083,970— $0210,530SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-04-062026-04-083,970$12.65 $50.2K7,592SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-04-062026-04-083,970$18.01 $71.5K3,622SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-04-012026-04-03679— $0148,329SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-04-012026-04-03679$16.00 $10.9K3,622SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-04-012026-04-03679$8.04 $5.5K4,301SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-03-162026-03-185,992— $0149,008SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-03-162026-03-1819,500— $0214,500SEC↗
AVTX Avalo Therapeutics, Inc. S Sale2026-03-162026-03-1825,492$16.15 $411.7K3,622SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-03-162026-03-185,992$8.04 $48.2K29,114SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-03-162026-03-1819,500$12.65 $246.7K23,122SEC↗
AVTX Avalo Therapeutics, Inc. A Award deriv2026-02-262026-03-02105,000— $0105,000SEC↗
AVTX Avalo Therapeutics, Inc. F Tax w/h2025-12-102025-12-121,013$4.10 $4.2K3,622SEC↗
CGEM Cullinan Therapeutics, Inc A Award deriv2025-08-072025-08-0879,456— $079,456SEC↗
AVTX Avalo Therapeutics, Inc. A Award deriv2025-01-282025-01-30155,000— $0155,000SEC↗
AVTX Avalo Therapeutics, Inc. A Award deriv2024-07-152024-07-16234,000— $0234,000SEC↗
DICE DICE Therapeutics, Inc. D To issuer deriv2023-08-092023-08-0942,500— $00SEC↗
DICE DICE Therapeutics, Inc. A Award deriv2022-03-312022-04-0142,500— $042,500SEC↗